M
Mary W. Brown
Researcher at University of Rochester Medical Center
Publications - 53
Citations - 15490
Mary W. Brown is an academic researcher from University of Rochester Medical Center. The author has contributed to research in topics: Multicenter Automatic Defibrillator Implantation Trial & Cardiac resynchronization therapy. The author has an hindex of 29, co-authored 48 publications receiving 14652 citations. Previous affiliations of Mary W. Brown include Columbia University & University of Rochester.
Papers
More filters
Journal ArticleDOI
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
Arthur J. Moss,Wojciech Zareba,W. Jackson Hall,Helmut U. Klein,David J. Wilber,David S. Cannom,James P. Daubert,Steven L. Higgins,Mary W. Brown,Mark L. Andrews +9 more
TL;DR: In patients with a prior myocardial infarction and advanced left ventricular dysfunction, prophylactic implantation of a defibrillator improves survival and should be considered as a recommended therapy.
Journal ArticleDOI
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
Arthur J. Moss,W. Jackson Hall,David S. Cannom,James P. Daubert,Steven L. Higgins,Helmut U. Klein,Joseph H. Levine,Sanjeev Saksena,Albert L. Waldo,David J. Wilber,Mary W. Brown,Moonseong Heo +11 more
TL;DR: In this article, the authors studied whether prophylactic therapy with an implanted cardioverter-defibrillator, as compared with conventional medical therapy, would improve survival in this high-risk group of patients.
Journal ArticleDOI
Reduction in Inappropriate Therapy and Mortality through ICD Programming
Arthur J. Moss,Claudio Schuger,Christopher A. Beck,Mary W. Brown,David S. Cannom,James P. Daubert,Henry Greenberg,W. Jackson,David T. Huang,Josef Kautzner,Helmut U. Klein,Scott McNitt,Brian Olshansky,Morio Shoda,David J. Wilber,Wojciech Zareba +15 more
TL;DR: Programming of ICD therapies for tachyarrhythmias of 200 beats per minute or higher or with a prolonged delay in therapy at 170 beats perminute or higher, as compared with conventional programming, was associated with reductions in inappropriate therapy and all-cause mortality during long-term follow-up.
Journal ArticleDOI
Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator
Arthur J. Moss,Henry Greenberg,Robert B. Case,Wojciech Zareba,W. Jackson Hall,Mary W. Brown,James P. Daubert,Scott McNitt,Mark L. Andrews,Adam D. Elkin +9 more
TL;DR: These patients are at increased risk for heart failure and nonsudden cardiac death after device termination of VT or VF and should receive special attention for the prevention and management of progressive left ventricular dysfunction during long-term follow-up.
Journal ArticleDOI
Analysis of mortality events in the multicenter automatic defibrillator implantation trial (MADIT-II)☆
Henry Greenberg,Robert B. Case,Arthur J. Moss,Mary W. Brown,Elizabeth Carroll,Mark L. Andrews,Madit-Ii Investigators +6 more
TL;DR: The decrease in mortality with ICD therapy in MADIT-II is entirely due to a reduction inSCD, with similar reductions in SCD in a spectrum of subgroups stratified according to relevant baseline characteristics.